JWH-210

Synthetic cannabinoid
| JWH-210 | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 824959-81-1 |
| PubChem | 44418164 |
| DrugBank | |
| ChemSpider | 23249924 |
| KEGG | |
JWH-210 is a synthetic cannabinoid from the naphthoylindole family. It acts as a potent agonist of the CB1 receptor and CB2 receptor, with a slight preference for the CB2 receptor. JWH-210 is part of the JWH series of synthetic cannabinoids, which were developed by John W. Huffman in the 1990s for research purposes.
Chemical Structure[edit]
JWH-210 has the chemical formula C25H25NO. Its structure consists of a naphthalene ring substituted at the 1-position with an ethyl group and at the 4-position with a pentylindole group. The IUPAC name for JWH-210 is (4-ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone.
Pharmacology[edit]
JWH-210 is a potent agonist of the cannabinoid receptors, particularly the CB1 receptor and CB2 receptor. It has been found to have a higher affinity for the CB2 receptor compared to the CB1 receptor. This selectivity makes it of interest in research related to the endocannabinoid system and potential therapeutic applications.
Legal Status[edit]
JWH-210 is classified as a controlled substance in several countries. In the United States, it is listed as a Schedule I substance under the Controlled Substances Act. In the United Kingdom, it is classified as a Class B drug. Other countries, such as Canada and Germany, have also placed JWH-210 under their respective controlled substance regulations.
Research and Applications[edit]
JWH-210, like other synthetic cannabinoids, has been used in scientific research to study the endocannabinoid system and the effects of cannabinoid receptor activation. It has also been used in the development of new therapeutic agents targeting cannabinoid receptors. However, due to its potent effects and potential for abuse, its use is strictly regulated.
See Also[edit]
References[edit]
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
